Researcher Information
Researcher Basic Information
Researcher Information
Academic Background
Career
Current Work Situation
Work Situation After Establishment of College
Academic Society and Social Activity
Teacher Examination Outcome
Researcher Activity Information
Field of Research
Research Keyword
Research Theme
Committee Career
Reward
Teaching Experiences
Academic Thesis
MISC
Bibliography
Conference
Works
Social Contribution
Media Coverage
Academic contribution
Competitive research funds
Patents
Other
Basic information
Name
YASUI Kohichiroh
Belonging department
Occupation name
researchmap researcher code
5000049673
researchmap agency
Bukkyo University
Researcher Basic Information
Researcher Information
YASUI/Kohichiroh/ヤスイ/コウイチロウ
Academic Background
1982/04 1988/03 京都府立医科大学 医学部 医学科
1991/04 1995/03 京都府立医科大学 博士 医学研究科 内科学
Career
2018/04 佛教大学 教授
2003/04 2018/03 京都府立医科大学 准教授
2000/05 2003/03 東京医科歯科大学 助手
Current Work Situation
Work Situation After Establishment of College
Academic Society and Social Activity
Teacher Examination Outcome
Researcher Activity Information
Field of Research
Life Science/Tumor biology
Life Science/Gastroenterology
Research Keyword
Research Theme
Committee Career
Reward
2022/10 佛教大学学術賞
2016/06 日本肝臓学会 欧文機関誌『Hepatology Research』High Citation賞
2011/04 日本消化器病学会奨励賞
Teaching Experiences
Academic Thesis
佛教大学総合研究所共同研究成果報告論文集第13号 Withコロナ時代の看護学生に対するVR（仮想現実）臨床学習法の開発およびキャリアデザインの動向調査とその支援 安居幸一郎
植村小夜子
漆葉 成彦
小澤 一史
田尻 后子
坪山 直生
浜崎 優子
藪下 八重
阿部あかね
鬼頭 泰子
清水奈穂美
白井はる奈
田野中恭子
長谷川由香
濵吉 美穂
赤沢 真世
阿部 慈美
岡田 朱民
髙岡 寿江
早瀬 麻子
緒方 靖恵
山本 真子 共著 2025/03/25
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer./Terashima T
Morizane C
Ushiama M
Shiba S
Takahashi H
Ikeda M
Mizuno N
Tsuji K
Yasui K
Azemoto N
Satake H
Nomura S
Yachida S
Sugano K
Furuse J./Joint Author/Jpn J Clin Oncol.
Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma./Matsumura S
Ishikawa T
Yoshida J
Morita R
Sakakida T
Endo Y
Doi T
Hirose R
Inoue K
Dohi O
Yoshida N
Uchiyama K
Takagi T
Konishi H
Yasui K
Naito Y
Itoh Y./Joint Author/Cancers (Basel)
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach./Soda T
Gen Y
Terasaki K
Iwai N
Kitaichi T
Dohi O
Taketani H
Seko Y
Umemura A
Nishikawa T
Yamaguchi K
Moriguchi M
Konishi H
Naito Y
Itoh Y
Yasui K./Joint Author/Scientific Reports
SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma. Terasaki K
Gen Y
Iwai N
Soda T
Kitaichi T
Dohi O
Taketani H
Seko Y
Umemura A
Nishikawa T
Yamaguchi K
Moriguchi M
Konishi H
Naito Y
Itoh Y
Yasui K. Oncol Lett. 2021/04
Show All（24 Line）
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. Hirayuki Enomoto
Yoshiyuki Ueno
Yoichi Hiasa
Hiroki Nishikawa
Shuhei Hige
Yasuhiro Takikawa
Makiko Taniai
Toru Ishikawa
Kohichiroh Yasui
Akinobu Takaki
Koichi Takaguchi
Akio Ido
Masayuki Kurosaki
Tatsuya Kanto
Shuhei Nishiguchi Journal of gastroenterology 2021/02
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient
amino acid-defined diet with 45% fat. Shinya Okishio
Kanji Yamaguchi
Hiroshi Ishiba
Nozomi Tochiki
Kota Yano
Aya Takahashi
Seita Kataoka
Keiichiroh Okuda
Yuya Seko
Yu Liu
Hideki Fujii
Daiki Takahashi
Yusuke Ito
Junji Kamon
Atsushi Umemura
Michihisa Moriguchi
Kohichiroh Yasui
Takeshi Okanoue
Yoshito Itoh 共著 Scientific reports 2020/11
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study). Naohiro Okano
Chigusa Morizane
Shogo Nomura
Hideaki Takahashi
Hidetaka Tsumura
Hironaga Satake
Nobumasa Mizuno
Kunihiro Tsuji
Kazuhiko Shioji
Akinori Asagi
Kohichiroh Yasui
Sho Kitagawa
Tomomi Kashiwada
Atsushi Ishiguro
Masashi Kanai
Makoto Ueno
Takashi Ogura
Satoshi Shimizu
Kazutoshi Tobimatsu
Masayo Motoya
Koji Nakashima
Masafumi Ikeda
Takuji Okusaka
Junji Furuse International journal of clinical oncology 2020/10
Randomised
multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Masatoshi Kudo
Kazuomi Ueshima
Masafumi Ikeda
Takuji Torimura
Nobukazu Tanabe
Hiroshi Aikata
Namiki Izumi
Takahiro Yamasaki
Shunsuke Nojiri
Keisuke Hino
Hidetaka Tsumura
Teiji Kuzuya
Norio Isoda
Kohichiroh Yasui
Hajime Aino
Akio Ido
Naoto Kawabe
Kazuhiko Nakao
Yoshiyuki Wada
Osamu Yokosuka
Kenichi Yoshimura
Takuji Okusaka
Junji Furuse
Norihiro Kokudo
Kiwamu Okita
Philip James Johnson
Yasuaki Arai Gut 2020/08
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. Hirayuki Enomoto
Yoshiyuki Ueno
Yoichi Hiasa
Hiroki Nishikawa
Shuhei Hige
Yasuhiro Takikawa
Makiko Taniai
Toru Ishikawa
Kohichiroh Yasui
Akinobu Takaki
Koichi Takaguchi
Akio Ido
Masayuki Kurosaki
Tatsuya Kanto
Shuhei Nishiguchi Journal of gastroenterology 2020/03
Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice. Hiroyoshi Taketani
Taichiro Nishikawa
Hisakazu Nakajima
Kazuki Kodo
Satoru Sugimoto
Wataru Aoi
Shin-Ichi Horike
Makiko Meguro-Horike
Hiroshi Ishiba
Yuya Seko
Atsushi Umemura
Kanji Yamaguchi
Michihisa Moriguchi
Kohichiroh Yasui
Yoshito Itoh Diabetes
metabolic syndrome and obesity : targets and therapy 2019/08
Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB-4 index. Yuya Seko
Michihisa Moriguchi
Tasuku Hara
Seita Kataoka
Keiichiroh Okuda
Mitsuhiro Furuta
Masashi Takemura
Hiroyoshi Taketani
Atsushi Umemura
Taichiro Nishikawa
Kanji Yamaguchi
Kohichiroh Yasui
Masahito Minami
Yoshito Itoh Hepatology research 2019/04
Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients. Toshihide Shima
Hirofumi Uto
Kohjiro Ueki
Yutaka Kohgo
Kohichiroh Yasui
Naoto Nakamura
Tatsuaki Nakatou
Toshinari Takamura
Sumio Kawata
Kazuo Notsumata
Kyoko Sakai
Ryosuke Tateishi
Takeshi Okanoue Journal of gastroenterology 2019/01
Phase I/II study of first-line combination therapy with sorafenib plus resminostat
an oral HDAC inhibitor
versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients. Won Young Tak
Baek-Yeol Ryoo
Ho Yeong Lim
Do-Young Kim
Takuji Okusaka
Masafumi Ikeda
Hisashi Hidaka
Jong-Eun Yeon
Eishiro Mizukoshi
Manabu Morimoto
Myung-Ah Lee
Kohichiroh Yasui
Yasunori Kawaguchi
Jeong Heo
Sojiro Morita
Tae-You Kim
Junji Furuse
Kazuhiro Katayama
Takeshi Aramaki
Rina Hara
Takuya Kimura
Osamu Nakamura
Masatoshi Kudo Investigational new drugs 2018/12
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. Yuya Seko
Taichiro Nishikawa
Atsushi Umemura
Kanji Yamaguchi
Michihisa Moriguchi
Kohichiroh Yasui
Mayumi Kimura
Hiroaki Iijima
Toshio Hashimoto
Yoshio Sumida
Takeshi Okanoue
Yoshito Itoh Diabetes
metabolic syndrome and obesity : targets and therapy 2018/11
Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma. Naoto Iwai
Kohichiroh Yasui
Akira Tomie
Yasuyuki Gen
Kei Terasaki
Tomoko Kitaichi
Tomohiro Soda
Nobuhisa Yamada
Osamu Dohi
Yuya Seko
Atsushi Umemura
Taichiro Nishikawa
Kanji Yamaguchi
Michihisa Moriguchi
Hideyuki Konishi
Yuji Naito
Yoshito Itoh 2018/07
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class. Eiichiro Suzuki
Shuichi Kaneko
Takuji Okusaka
Masafumi Ikeda
Kensei Yamaguchi
Rie Sugimoto
Takeshi Aramaki
Akinori Asagi
Kohichiroh Yasui
Keiji Sano
Ayumu Hosokawa
Naoya Kato
Hiroshi Ishii
Tosiya Sato
Junji Furuse Japanese journal of clinical oncology 2018/04
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. Yuya Seko
Kanji Yamaguchi
Naoki Mizuno
Keiichiro Okuda
Masashi Takemura
Hiroyoshi Taketani
Tasuku Hara
Atsushi Umemura
Taichiro Nishikawa
Michihisa Moriguchi
Kohichiroh Yasui
Mai Kamaguchi
Kenichi Nishioji
Naomi Mochizuki
Masao Kobayashi
Kojiroh Mori
Saiyu Tanaka
Kentaro Matsuura
Yasuhito Tanaka
Yoshito Itoh Journal of gastroenterology 2018/03
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. Yuya Seko
Yoshio Sumida
Saiyu Tanaka
Kojiroh Mori
Hiroyoshi Taketani
Hiroshi Ishiba
Tasuku Hara
Akira Okajima
Atsushi Umemura
Taichiro Nishikawa
Kanji Yamaguchi
Michihisa Moriguchi
Kazuyuki Kanemasa
Kohichiroh Yasui
Shunsuke Imai
Keiji Shimada
Yoshito Itoh Hepatology research 2018/02
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma./安居幸一郎 他/Joint Author/Clin Gastroenterol Hepatol
Alteration in copy numbers of genes as a mechanism for acquired drug resistance./安居幸一郎 他/Joint Author/Cancer Res
TFDP1
CUL4A
and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas./安居幸一郎 他/Joint Author/Hepatology
The native form and maturation process of hepatitis C virus core protein./安居幸一郎 他/Joint Author/J Virol
Dynamics of hepatitis C viremia following interferon-alpha administration./安居幸一郎 他/Joint Author/J Infect Dis
Collapse The View
MISC
Bibliography
Conference
Works
Social Contribution
Media Coverage
Academic contribution
Competitive research funds
キネシン分子モーターを構成するKAP3の異常が胃印環細胞癌の発生に関与する機序 日本学術振興会 科学研究費助成事業 2021/04 2023/03
Patents
Other
